文献速递中医内科中药与中成药合理使用

Buddleja globosa Hope(玄参科)的植物化学、药理、安全性与应用:从生物活性代谢物与机制到转化前景的系统综述

Phytochemistry, pharmacology, safety, and applications of Buddleja globosa Hope [Scrophulariaceae]: a systematic review from bioactive metabolites and mechanisms to translational perspectives.
PubMed 文献 · Front Pharmacol · 2026-10-14

该文按PRISMA 2020指南系统检索多数据库,纳入50项研究,综述智利传统草药Buddleja globosa(matico/pañil)的传统用途、植物化学、药理活性与安全性。其叶水提物口服或外用,在胃溃疡与皮肤创面愈合方面证据较突出;含119种生物活性代谢物,但精油表征不足,并在种植、化学标准化、毒理与临床验证方面存在知识空白。

要点

  • 叶水提物口服或外用,胃溃疡与皮肤创面愈合为其证据较突出的适应症
  • 含verbascoside、echinacoside、buddledin A、α/β-amyrin、luteolin、apigenin等119种生物活性代谢物
  • 精油表征不足,化学标准化、毒理安全评价与临床验证仍待完善

核心结论

  • Buddleja globosa因长期传统使用、在智利广泛使用及渐增的科学证据而成为战略性药用资源,尤其在创面愈合应用方面。
  • 综述记录了verbascoside、amyrins与黄酮类等多种生物活性代谢物。
  • 未来研究应聚焦知识转化策略与推行良好生产规范的公共政策,将其使用转化为循证医疗。

研究设计与样本

  • 系统综述,遵循PRISMA 2020指南,检索Web of Science、Scopus、PubMed、SciFinder、智利大学仓储及灰色文献。
  • 共纳入50项研究,覆盖传统用途、民族药理学、植物化学与生物活性。
  • 系统综述注册号:PROSPERO CRD420261450024。

主要发现

  • 传统用途使该物种成为智利最重要的药用植物之一,内服与外用兼有,但各适应症的证据强度不一。
  • 治疗胃溃疡与促进皮肤创面愈合的用途尤为值得注意,其药理活性在体外研究、小鼠模型与临床试验中均有报告。
  • 该物种含119种生物活性代谢物,包括verbascoside、echinacoside、buddledin A、α-amyrin、β-amyrin、luteolin与apigenin,但精油仍表征不足。
  • 已识别的重要知识空白包括药用栽培与营林管理、化学标准化、代谢组变异性、毒理与安全性评价及临床前与临床验证。

关键数值与推荐

  • 纳入研究数:50项。
  • 生物活性代谢物:119种。
  • 主要代谢物举例:verbascoside、echinacoside、buddledin A、α-amyrin、β-amyrin、luteolin、apigenin。

临床怎么用

  • 该物种叶水提物在智利有逾百年传统用于口服或外用,可作胃溃疡与皮肤创面愈合的候选草药,但应结合证据强度分级看待各适应症。
  • 用于转化开发时需关注化学标准化、代谢组变异与毒理安全评价等尚未解决的环节。

局限性

  • 精油表征不足。
  • 药用栽培与营林管理、化学标准化、代谢组变异性、毒理与安全性评价、临床前与临床验证方面存在知识空白。
  • 各适应症的证据强度不一。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Buddleja globosa Hope [Scrophulariaceae] is a shrub native to South America, known in Chile as matico or pañil. Its leaves are widely used in traditional medicine and have commercial applications, primarily as aqueous extracts administered orally or topically. Its use is supported by over a century of traditional practice, and it is one of the few native species recognized as a traditional herbal medicine in Chile based on long-standing use and emerging scientific evidence. METHODOLOGY: We retrieved bibliographic data on the traditional uses, ethnopharmacology, phytochemistry, and biological activities of B. globosa from Web of Science®, Scopus®, PubMed®, SciFinder®, University of Chile Repository® and grey literature. We conducted a systematic review in accordance with the PRISMA 2020 guidelines. RESULTS AND DISCUSSION: Fifty studies were included in the systematic review. Traditional uses have made B. globosa one of the most important medicinal plant species in Chile for both internal and topical applications, although the strength of evidence varies by indication. Its use in treating gastric ulcers and promoting skin wound healing is particularly noteworthy, with pharmacological activities reported in in vitro studies, murine models, and clinical trials. The species contains a remarkable diversity of bioactive metabolites (n = 119), including verbascoside, echinacoside, buddledin A, α-amyrin, β-amyrin, luteolin, and apigenin; however, its essential oil remains poorly characterized. Furthermore, the review identified important knowledge gaps, particularly in medicinal cultivation and silvicultural management, chemical standardization, metabolomic variability, toxicological and safety assessment, and preclinical and clinical validation. Addressing these gaps will be essential to support the development of standardized phytotherapeutic products based on B. globosa. CONCLUSION: Buddleja globosa represents a strategic medicinal resource due to its long history of traditional use, its widespread use in Chile, and the growing body of scientific evidence suggesting its biological properties, particularly in wound-healing applications. This review documents several bioactive metabolites, including verbascoside, amyrins, and flavonoids. In this context, future research should focus on strategies that promote knowledge transfer and on developing public policies to implement Good Manufacturing Practices, translating their use into evidence-based healthcare. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420261450024.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Fuentes-Barros, Castro-Saavedra, Montalva, et al. Phytochemistry, pharmacology, safety, and applications of Buddleja globosa Hope [Scrophulariaceae]: a systematic review from bioactive metabolites and mechanisms to translational perspectives. Front Pharmacol. 2026. PMID: 42952893. doi:10.3389/fphar.2026.1940132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。